Early Signs Point to a Harsh Flu Season in the U.S.

The United States may be headed for a rough flu season, with a virus that causes more severe symptoms than the one last year ...
MyChamplainValley.com

Flu activity still low in Vermont – what health officials say

Vermont added only 9 positive flu tests in Friday’s report, but those numbers will increase. Health officials are suggesting ...

Avian flu warning system alerts for cross-species transmission

How can we monitor the cross-species transmission of avian flu? The answer is FluWarning, a digital system that reports ...

Senior government adviser 'astonished' at Ministers' failure to act swiftly on warnings Covid virus was 'vastly more dangerous' to the elderly

A senior advisor to the Scottish Government has said he was 'astonished' at Ministers' failure to act swiftly on clear ...

What is the H3N2 flu strain? Symptoms you need to look out for as UK cases surge

The symptoms and severity of H3N2 illness have been similar to seasonal flu, including fever, cough, runny nose, and possibly ...

NMMC Inaugurates Advanced Microbiology Lab At Nerul’s Meenatai Thackeray Hospital

Navi Mumbai: Navi Mumbai Municipal Corporation (NMMC) on Thursday inaugurated an advanced microbiology laboratory at the ...

BORIS JOHNSON: On Covid there are two big questions: Where did the virus come from – and were the lockdowns worth the terrible price we paid? Baroness Hallett’s …

What is in the news in Britain, asks BORIS JOHNSON. What are they talking about? You rub your eyes in sheer amazement. Covid!

Investornewsbreaks Nanoviricides (NYSE American: NNVC) Files Quarterly Report Highlighting Broad-Spectrum Antiviral Candidate NV-387

Files Quarterly Report Highlighting Broad-Spectrum Antiviral Candidate NV-387. NanoViricides, Inc. (NYSE American: NNVC) filed its Form 10-Q for the quarter ended Sept. 30, 2025, and detailed progress ...
Daily Mirror

First U.S. case of human bird flu in 9 months confirmed in Washington state

The person was infected with a strain that has previously been reported in animals but never before in humans. ..

NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th – NV-387 is Effective Against H3N2

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...